Form EFFECT Xeris Biopharma Holdings
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2025 4:01 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- T-Mobile and Jio Achieve World’s First 5G Standalone Roaming
- From GABA to Goji: A Scientific Benchmark for Functional Ingredients in Asia Takes Shape in Zhangzhou
- SQAIRZ ADDS BLACK AND WHITE COLORWAYS TO 2026 XRZ2™ PICKLEBALL FOOTWEAR LINE
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
